Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53

被引:85
作者
Hofmann, CS [1 ]
Sonenshein, GE [1 ]
机构
[1] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
关键词
p21(CIP1); NF-kappa B; p50; p65; I kappa B;
D O I
10.1096/fj.02-0665fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Green tea polyphenols (GTPs), which possess antioxidant properties, have been shown to inhibit the development of atherosclerotic lesions. Epigallocatechin-3-gallate (EGCG), the most abundant GTP, displays antiproliferative effects in a variety of cell types. Here, we examined the effects of GTPs on aortic smooth muscle cell (SMC) proliferation. Treatment with a GTP mixture or EGCG at a dose of 40 to 50 mug/ml slowed SMC growth, while at a higher dose of 80 mug/ml EGCG also induced cell death as judged by TUNEL assay. Apoptosis was mainly observed in proliferating SMCs in subconfluent cultures; whereas at higher confluency, cell viability was largely unaffected. Treatment with 80 mug/ml EGCG induced the tumor suppressor p53, which was functional as judged by activation of the target cyclin-dependent kinase inhibitor p21(CIP1). Inhibition of p53 activity with a dominant negative mutant reduced cell death. The increase in p53 protein was due to increased stability. EGCG also induced functional nuclear factor-kappaB (NF-kappaB) complexes, and inhibition of this activity reduced the extent of cell death. Thus, EGCG inhibits growth and induces death of SMCs in a p53- and NF-kappaB-dependent manner. These results provide evidence for a new molecular mechanism whereby green tea polyphenols inhibit SMC proliferation and function to prevent the development of atherosclerosis.
引用
收藏
页码:702 / +
页数:19
相关论文
共 48 条
[1]   Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor κB in cancer cells versus normal cells [J].
Ahmad, N ;
Gupta, S ;
Mukhtar, H .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 376 (02) :338-346
[2]   Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172) [J].
Ahn, HY ;
Hadizadeh, KR ;
Seul, C ;
Yun, YP ;
Vetter, H ;
Sachinidis, A .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (04) :1093-1104
[3]   p53-Mdm2 - the affair that never ends [J].
Alarcon-Vargas, D ;
Ronai, Z .
CARCINOGENESIS, 2002, 23 (04) :541-547
[4]   CELL-CYCLE REGULATION OF MOUSE H-3 HISTONE MESSENGER-RNA METABOLISM [J].
ALTERMAN, RBM ;
GANGULY, S ;
SCHULZE, DH ;
MARZLUFF, WF ;
SCHILDKRAUT, CL ;
SKOULTCHI, AI .
MOLECULAR AND CELLULAR BIOLOGY, 1984, 4 (01) :123-132
[5]   Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells - Potential role of p53 in regulation of vascular smooth muscle cell growth [J].
Aoki, M ;
Morishita, R ;
Matsushita, H ;
Hayashi, S ;
Nakagami, H ;
Yamamoto, K ;
Moriguchi, A ;
Kaneda, Y ;
Higaki, J ;
Ogihara, T .
HYPERTENSION, 1999, 34 (02) :192-200
[6]   Control of apoptosis by Rel/NF-κB transcription factors [J].
Barkett, M ;
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6910-6924
[7]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[8]   APOPTOSIS OF RAT VASCULAR SMOOTH-MUSCLE CELLS IS REGULATED BY P53-DEPENDENT AND P53-INDEPENDENT PATHWAYS [J].
BENNETT, MR ;
EVAN, GI ;
SCHWARTZ, SM .
CIRCULATION RESEARCH, 1995, 77 (02) :266-273
[9]   Additive effect between NF-κB subunits and p53 protein for transcriptional activation of human p53 promoter [J].
Benoit, V ;
Hellin, AC ;
Huygen, S ;
Gielen, J ;
Bours, V ;
Merville, MP .
ONCOGENE, 2000, 19 (41) :4787-4794
[10]   ADENOVIRUS-MEDIATED OVER-EXPRESSION OF THE CYCLIN CYCLIN-DEPENDENT KINASE INHIBITOR, P21 INHIBITS VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND NEOINTIMA FORMATION IN THE RAT CAROTID-ARTERY MODEL OF BALLOON ANGIOPLASTY [J].
CHANG, MW ;
BARR, E ;
LU, MM ;
BARTON, K ;
LEIDEN, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2260-2268